AI for R&D: Episode 4 | Positively disrupting pharmaceutical R&D with AI/ML

Nathan Sommerford, Global Lead of AI for Drug Discovery & Development at IQVIA, discusses how AI/ML is disrupting R&D across the board.  In this episode: How working in synergy with clinicians and research scientists, AI/ML can provide a much-needed augmentation to how drugs are developed.  Understand where to apply AI, whether it's early in drug discovery, to find the right patient subpopulations or to do disease modeling.  Explore using a machine learning approach based on fairness ranking systems to best represent a clinical trial patient base and address the challenge of diversity and inclusion. 

Om Podcasten

The pace of change in healthcare is accelerating. Our understanding of how data, technology and scientific expertise can come together is only getting more precise. In this podcast, leaders from IQVIA lead discussions on the issues, innovations, and collaborations that are making an impact on health and business outcomes. Topics will include new approaches to clinical development, leading-edge technologies and methodologies that extract more value (and less work) from healthcare data, and strategies that ensure the right medicines get to the right patients, faster. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare - and human health - forward.